富可伊丹降解产品在改善食后高血糖症的多种机制
Luying Tang1, Mengshi Xiao1, Shenyuan Cai1
1College of Food Science and Engineering, Ocean University of China, No. 1299 Sansha Road, Qingdao, 266404, Shandong, People's Republic of China.
International journal of biological macromolecules
|November 4, 2025
概括
富可伊丹降解产品 (FUDPs) 通过抑制消化酶和增强胰岛素敏感性,有效地控制血糖. 这些发现提供了对富可伊丹的洞察力.
科学领域:
- 海洋生物技术 海洋生物技术
- 营养生物化学 营养生物化学
- 糖尿病研究 糖尿病研究
背景情况:
- 饭后高血糖会加速糖尿病的进展.
- 富可伊丹降解产品 (FUDP) 显示出有希望的低血糖效应.
- 需要阐明FUDPs抗高血糖作用背后的机制.
研究的目的:
- 研究低/高分子量FUDPs (LMAF/HMAF) 的低血糖机制.
- 探索FUDPs对消化酶抑制和胰岛素抵抗的影响.
- 阐明FUDPs在调节食后葡萄糖中的作用.
主要方法:
- 在体外消化酶抑制试验 (α-氨基酶,α-葡萄糖酶).
- 在体内研究使用胰岛素耐药性小鼠模型.
- 分析与胰岛素分泌和葡萄糖运输相关的基因表达.
主要成果:
- 通过静态火,FUDPs可逆抑制α-氨酶和α-葡萄糖酶.
- HMAF改变了α-氨酶的二次结构.
- 通过高调节GLP-1和GIP,HMAF提高了胰岛素分泌和敏感性.
- FUDPs降低了PKCα/SGLT1/GLUT2通路的调节,控制了葡萄糖峰值.
结论:
- FUDPs (<20 kDa) 通过多种机制调节食后高血糖症.
- 这项研究提供了关于福柯丹结构与活动关系的见解.
- FUDPs代表了低血糖功能食品的潜在候选人.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
513
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
513
Dipeptidyl Peptidase 4 Inhibitors
574
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
574
Glucagon-like Receptor Agonists
832
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
832
Oral Hypoglycemic Agents: Glinides
585
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
585
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K


